Columbia’s Prochieve Could Get Competitive Edge From Committee Review Of Rival Product
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA panel review of Adeza’s Gestiva endorses endpoints being used in Columbia’s Phase III trial of its preterm birth agent.